Search Results 1101-1110 of 13332 for monoclonal antibody

1. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

   A history of hypersensitivity to other humanized monoclonal antibodies. Significant cardiovascular disease (New York Heart Association Class II or greater) ...

2. ASPEN-09: A Study Of Evorpacept In Combination With Anti-cancer Therapies In Advanced / Metastatic Malignancies - Mayo Clinic

   Immune therapy or other biologic therapy (e.g., monoclonal antibodies, antibody-drug conjugates) for the treatment of cancer for: 28 days or 5 half-lives ( ...

3. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody In Solid Tumors - Mayo Clinic

   A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody In Solid Tumors · Share · Facebook · Twitter.

4. A Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of RO7303509 In Participants With Systemic Sclerosis - Mayo Clinic

   monoclonal antibodies. - Immunization with a live/attenuated vaccine within ... study or within 3 months after the final dose. - Positive hepatitis C virus (HCV) ...

5. Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody optic neuritis

   Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody optic neuritis ... Two novel glial autoantibodies discovered in the past 15 years enable ...

6. Study Of Relacorilant In Combination With Pembrolizumab For Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

   History of severe hypersensitivity to another monoclonal antibody. Other concurrent cancer or a history of another invasive malignancy within the last 3 ...

7. Phase III Study Of Datopotamab Deruxtecan Versus Docetaxel In Previously Treated TROP2-positive Advanced Or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations - Mayo Clinic

   ... monoclonal antibody (mAb) as the only prior line of therapy or received PBC and anti-PD-1/anti-PD-L1 monoclonal antibody (in either order) sequentially as ...

8. Mayo Clinic Podcast - Dr. Gregory Poland - YouTube Audio Exp...

   antibody levels. So when exposed, they could develop disease ... Some of the mutations are making vaccines, plasma, monoclonal antibodies less effective.

9. Publications - Pablo Moreno Franco, M.D. - Mayo Clinic

   ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Shah SZ, Alvarez FG, Sanghavi ...

10. A Study Of JNJ-68284528, A Therapy Directed Against B-Cell Maturation Antigen (BCMA) In Participants With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    Monoclonal antibody treatment for multiple myeloma within 21 days;; Cytotoxic therapy within 14 days;; Proteasome inhibitor therapy within 14 days ...